At Seattle Cancer Care Alliance, treatment is available for every type of brain cancer and tumor, including meningiomas, gliomas, vestibular schwannomas, central nervous system lymphomas, and metastatic cancers in the brain and spinal cord.
Our expert team of doctors includes medical oncologists, radiation oncologists, and surgeons who work as a team to evaluate and plan each patients' care. State-of-the-art rehabilitation services are also available.
The mission of SCCA’s neuro-oncology team is to provide the best possible patient-focused care and leading-edge treatment. We will help you understand your condition and your options for dealing with your cancer.
Getting the best new treatments to patients is another goal of our team. Read more about "bench to bedside," a concept that most all medical discoveries are based on. Physician researchers find new treatments in the laboratory and through clinical trials, bring them to patients.
Continuing Medical Education and Patient Events
CME: Spotlight Understanding the Clinical Applicability of Integrin Inhibition in the Treatment of Glioblastoma supported by EMD Serono is now online. Integrins play a crucial role in tumor signaling, survival, migration, and angiogenesis, making them potent targets for cancer therapy, particularly for gliomas and glioblastomas. Several integrin inhibitors are being studied and have been shown to be effective with minimal side effects. This activity will provide an overview of integrin biology and the role of anti-integrins in the treatment of glioblastomas.